EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Disparities and barriers to the access of biologics in moderate‐to‐severe adult psoriasis

Vincent Wan iD, Alireza Habibi, Lorena A Mija iD, Parsa Abdi iD, Rishika Selvakumar, Ilya Mukovozov iD

International Journal of Dermatology · 2024-10 · 63 (10) · 1293-1301

DOI: 10.1111/ijd.17236 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Dermatology, online erschienen am 06.06.2024. Verfasst von Vincent Wan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. Hauptthemen laut MEDLINE: Psoriasis, Health Services Accessibility, Biological Products, Healthcare Disparities. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is a chronic, relapsing inflammatory skin disorder that is associated with substantial physical and psychosocial comorbidity. Although biologic agents have offered transformative therapeutic advantages to those unresponsive to traditional treatments, data from recent literature indicate significant undertreatment of certain populations, highlighting potential barriers to access. This review aims to comprehensively elucidate barriers to biological therapy, addressing a recognized gap in the current literature. A search was conducted using MEDLINE, Embase, and Web of Science to investigate the obstacles and disparities that prevent access to biologic treatments in biologic‐naïve psoriatic patients. Emergent themes were then systematically categorized into five primary domains: patient‐level, prescriber‐level, medicine‐level, organizational‐, and external environment‐level factors. Our results demonstrate pronounced barriers and disparities encompassing increased age, race, socioeconomic status, rural location, cost and insurance, and insufficient knowledge that may hinder access to biologic treatments among psoriatic patients. Further research on how these barriers can be effectively addressed is needed to optimize treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisHealth Services AccessibilityBiological ProductsHealthcare DisparitiesSeverity of Illness IndexHumansAdultAge FactorsSocial ClassInsurance, HealthHealth Knowledge, Attitudes, PracticeRural PopulationInsurance CoverageSocioeconomic FactorsDermatologic Agents

Stichwörter der Autor:innen

Skin of Color (SOC)accessbarriersbiologicsdisparityethnicitypsoriasisraceruralsocioeconomic status

Substanzen

Biological ProductsDermatologic Agents

Autor:innen und Institutionen

  • Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Faculté de Médecine, Université de Montréal, Montréal, QC, Canada.
  • Memorial University of Newfoundland Faculty of Medicine, St. Johns, NL, Canada.
  • University of British Columbia, Vancouver, BC, Canada.
  • Toronto Dermatology Centre, Toronto, ON, Canada.

ORCID-Profile: Vincent Wan, Lorena A Mija, Parsa Abdi, Ilya Mukovozov

Zitieren

APA

Wan, V., Habibi, A., Mija, L. A., Abdi, P., Selvakumar, R., & Mukovozov, I. (2024). Disparities and barriers to the access of biologics in moderate‐to‐severe adult psoriasis. International Journal of Dermatology, 63(10), 1293-1301. https://doi.org/10.1111/ijd.17236

Vancouver

Wan V, Habibi A, Mija LA, Abdi P, Selvakumar R, Mukovozov I. Disparities and barriers to the access of biologics in moderate‐to‐severe adult psoriasis. International Journal of Dermatology. 2024;63(10):1293-1301. doi:10.1111/ijd.17236

BibTeX
@article{Wan2024,
  author = {Wan, Vincent and Habibi, Alireza and Mija, Lorena A and Abdi, Parsa and Selvakumar, Rishika and Mukovozov, Ilya},
  title = {Disparities and barriers to the access of biologics in moderate‐to‐severe adult psoriasis},
  journal = {International Journal of Dermatology},
  year = {2024},
  volume = {63},
  number = {10},
  pages = {1293--1301},
  doi = {10.1111/ijd.17236}
}
Kostenlos starten →